Clinical Trial

Assessment of Venous Return During Volume Expansion: a Prospective Observational Study

Study acronym: PSM-PVC-RITVEN
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 30, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
According to Guyton's model of venous return, the fluids that effectively increase cardiac output are those that, once administered, increase the vascular stressed volume, thereby increasing the mean systemic filling pressure (Pms) without increasing the central venous pressure (CVP). In this way, since the gradient between Pms and CVP increases, venous return-and consequently cardiac output-also increases. In cases where physiologically ineffective fluids are administered, the situation arises in which, in addition to increasing the stressed volume and thus Pms, CVP also increases. As a result, the gradient between Pms and CVP remains unchanged, and cardiac output does not increase. The hypothesis is that only a portion of the fluids administered during volume expansion are actually effective in increasing the gradient between Pms and CVP.
Trial Details
NCT Number NCT07499388
Lead Sponsor Università Politecnica delle Marche
Conditions Hemodynamic Changes
Enrollment 45 participants
Start Date 2025-03-01
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-03-30